For the early diagnosis of HELLP syndrome, some studies suggest using novel genetic biomarkers in association with laboratory markers, new potential tools with clinical utility (Galectin-1 and p65/RelA immunoexpression of placental NF-kB) [15,16] (Table 2). This evidence concerns the gene RELA and HELLP syndrome.